ChemotherapyFDA-approvedFirst-line
Fludarabine
How it works
Interferes with DNA synthesis, preventing cancer cells from growing and dividing.
Cancer types
Leukemia— All patients
Efficacy
In clinical trials, around 30% of patients achieved a complete remission, with median overall survival of approximately 8 months.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
Evidence from research
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.